Protecting brain networks to stop brain disease.
We are forging new frontiers in brain health
Cellestial Health is a preclinical biopharmaceutical company transforming the future of brain disease therapies by focusing on astrocytic networks, an often-overlooked yet critical component of brain function.
Our innovative approach targets the root causes of neurodegenerative diseases like Parkinson’s, aiming to halt disease progression where current treatments only manage symptoms.
Led by a team of experts committed to scientific innovation and driven by a mission to improve patient outcomes, Cellestial Health is advancing a groundbreaking discovery pipeline.
Our therapies not only hold the potential to change lives but also to redefine how we understand and treat complex brain diseases on a fundamental scientific level.
Innovating where other drugs fall short
As Parkinson’s continues to rise as one of the fastest-growing neurological disorders globally, current treatments primarily mask symptoms rather than halting disease progression.
At Cellestial Health, we’re tackling this head-on by focusing on both motor and non-motor symptoms through our innovative, brain-penetrant small molecules.